Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
about
Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group StudyPre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group studyMuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures.Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer.Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancerNucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.Taxane pathway.Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?Platinum-induced neurotoxicity and preventive strategies: past, present, and futureInformative gene network for chemotherapy-induced peripheral neuropathyComparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy.Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.Germline pharmacogenetics of paclitaxel for cancer treatment.Genetic markers for prediction of treatment outcomes in ovarian cancer.Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells.Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial.Copy number changes of 4-gene set may predict early relapse in advanced epithelial ovarian cancer after initial platinum-paclitaxel chemotherapy.Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapy.Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.SNPs and taxane toxicity in breast cancer patients.APEX microarray panel for genotyping polymorphisms in cancer chemotherapy and estimation frequencies in a Slovak population.Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.Single nucleotide polymorphisms (SNPs) of hOGG1 and XRCC1 DNA repair genes and the risk of ovarian cancer in Polish women.Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
P2860
Q30417640-734327BE-4BF1-403D-B5EB-A1F36A967466Q30419554-11FA5FBD-8AB9-4F0C-9BCA-B217EA78EB40Q30432282-60826835-EA42-4F11-84DE-4D5EFC838A44Q33418358-72C81E6E-0778-4AF8-ABAC-B136DD2DC1D7Q33422082-AFADC6BA-F4D3-4500-B49B-B714DAF425E5Q33985880-4A985C78-4987-4517-9811-C47D7796AE53Q34390370-61116B73-639E-431B-B3C9-C3B84600945DQ35031998-7329B118-FF76-4173-BE8B-9044FF376862Q35196724-DBB19F9A-79AD-41C8-9659-DC49FE0345FEQ35345734-C7EC8A96-D2EA-47C2-8EE2-E6645BEE1F20Q35945680-4DEB160E-2CD4-400F-9B78-0A2A32BD91D9Q36457582-50093E13-F753-40AB-8034-41DB53758D9EQ37576360-16040191-FB00-455D-ACE2-24A89BDCD867Q37684533-2EB4C257-94C9-442F-85B8-E0C36C766F66Q38065218-AE712E2B-CFCA-46FF-B062-6A38E41BD6D9Q38120289-400D217A-0D90-4D81-BD7F-CE034F7CD56FQ38227080-28C57099-D0E9-45BB-8932-69B3F674404CQ38276429-22A168CA-C133-4DA1-988F-5A99A9473567Q38551666-9898DDAE-BAF7-4022-8714-518DC365CDD4Q38758230-E49F1C2E-6DF7-4FDB-9527-269535DE9ADFQ39430809-5EED6548-F4DB-4AE9-AF73-E744CA6080A7Q39702921-F379F67C-A4DA-451F-9F96-3340C050BCE6Q40715631-CE21ADAA-A4A6-411A-862F-49D4D25BCCBDQ40950661-51757E7A-F0B2-4389-BB4C-9D4AA0CD58CEQ40955139-65D76D58-AEF1-4F43-A87D-3FA4961B059AQ43655173-36DF1E9D-F337-439D-8813-81680121637FQ43951894-041FAED0-21FC-49F5-AA71-3E07A5A13303Q45866994-D7947D03-E0F1-417B-9CA3-78B54BC9C895Q45963809-48B0A6BB-503E-4BA0-9DA5-938BB6DF63A9Q46063656-F9C6E8FD-F98F-46D3-83FA-0850BDC0D5BAQ46800256-3372B404-08A3-4F69-B882-0A02AC0C897EQ50108965-94ACF624-B34D-4D96-91A5-347ECDE1AD20Q51436755-DCDFC9B5-E21D-4FBC-B3BF-DCB95099CA2FQ53135936-20727E89-273B-4136-B132-2311EF804AA2Q53448036-88DE49BE-3F85-42F0-AAF5-8E446F428E2BQ57581249-469B66EA-E655-453A-B961-4C8DE225767E
P2860
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Genetic polymorphisms affectin ...... Korean population-based study.
@en
Genetic polymorphisms affectin ...... Korean population-based study.
@nl
type
label
Genetic polymorphisms affectin ...... Korean population-based study.
@en
Genetic polymorphisms affectin ...... Korean population-based study.
@nl
prefLabel
Genetic polymorphisms affectin ...... Korean population-based study.
@en
Genetic polymorphisms affectin ...... Korean population-based study.
@nl
P2093
P1433
P1476
Genetic polymorphisms affectin ...... Korean population-based study.
@en
P2093
Hee Seung Kim
Hyun Hoon Chung
Jae Weon Kim
Mi-Kyung Kim
Noh Hyun Park
Soon Beom Kang
Yong Sang Song
P304
P356
10.1016/J.YGYNO.2009.01.002
P407
P577
2009-02-08T00:00:00Z